Larimar Therapeutics Reports Second Quarter 2025 Financial Results

Go back to Larimar Therapeutics Reports Second Quarter 2025 Financial Results
(NASDAQ: LRMR) Delayed: 4.27 -0.1 (2.29%)
Previous Close $4.37    52 Week High
Open $4.38    52 Week Low
Day High $4.47    P/E N/A 
Day Low $4.23    EPS
Volume 1,502,798